WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 132
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 152

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 31'568  31'155  30'738  30'318  29'893  24'488  19'862  15'344 
Births 601  602  603  604  604  583  576  501 
Surviving infants 593  594  595  596  596  571  562  482 
Pop. less than 5 years 2'974  2'975  2'975  2'972  2'967  2'823  2'764  2'288 
Pop. less than 15 years 8'806  8'783  8'760  8'732  8'701  8'364  7'531  6'295 
Female 15-49 years 8'310  8'228  8'149  8'068  7'984  6'421  4'993  3'678 

Number of reported cases

(Click for retrospective incidence data for Venezuela (Bolivarian Republic of))
Diphtheria
ChartChart
  31  31 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  22  9'881  9'750 
Mumps
ChartChart
  50  156  69  15  5'851 
Pertussis
ChartChart
  555  1'389  3'247 
Polio*
ChartChart
  11 
Rubella
ChartChart
  13'927 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  28  129 
Tetanus (total)**
ChartChart
  23  14  12  14  27  99  476 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Venezuela (Bolivarian Republic of))
Vaccine year result method % card seen                                                
BCG 1999  90  MICS     99*  99  95  95  96  99  82  72 
DTP1 1999  88  MICS     99*  98  88  90  90  92 
DTP3 1999  59  MICS     84  87  78  82  81  77  63  56 
DTP4          52  50  46 
IPV1          68 
HepB_BD          56  89  82  80  67  14 
HepB3          84  87  78  82  81 
Hib3          84  87  78  82  81 
JapEnc         
MCV1          88  92  89  85  87  84  62  50 
MCV2          53  52  50  38  33 
MenA         
PCV1          19  78 
PCV2          14  63 
PCV3          24 
Pol3 1999  40  MICS     82  87  79  82  73  86  72  95 
Rota1          67  90  81  83  83 
RotaC          47  84  76  77  76 
RCV1          88  92  89  85  87 
TT2plus          45  52  34  48  51 
PAB         
VAD1         
YFV          84  85  82  85  87  17 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Venezuela (Bolivarian Republic of))
BCG
ChartChart
  99  99  97  95  96  99  82  72 
DTP1
ChartChart
  98  98  88  90  90  92  84  79 
DTP3
ChartChart
  84  87  78  82  81  77  63  56 
HepB3
ChartChart
  84  87  78  82  81 
HepB_BD
ChartChart
  56  64  72  80  67  14 
Hib3
ChartChart
  84  87  78  82  81 
IPV1
  68 
MCV1
ChartChart
  88  92  89  85  87  84  61  50 
MCV2
ChartChart
  53  52  50  38  33 
PCV3
ChartChart
  24 
Pol3
ChartChart
  82  87  79  82  73  86  72  95 
RCV1
ChartChart
  88  92  89  85  87  84 
RotaC
ChartChart
  47  84  76  77  76 
YFV
ChartChart
  84  85  82  85  87  17 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 335  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
99 
   
/
|
|
\
Greater or equal to 90% 58
From 80 to 89% 19
From 50 to 79% 20
Less than 50% 3
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 2, 4, 6, 18 months; 5 years; Yes
HepB_Adult 1st contact; +1, +6 months; Yes risk groups
HepB_Pediatric birth; Yes
Influenza_Adult > 60 years; Yes and adults with chronic diseases, pregnant women, health care workers and other risk groups
Influenza_Pediatric 6-23 months; Yes and children with chronic diseases
IPV 2 months; Yes
MMR 12 months; 5 years; Yes
OPV 4, 6, 18 months; 5 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps > 60 years; + 5 years; Yes
Rabies 1st contact; +3, +7, +14, +28 days; Yes post-exposure
Rotavirus 2, 4 months; Yes
Td 1st contact; +1, +6 months; +1, +1 year; Yes Y10 at school and CBAW
YF 1 year; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  Yes  Yes  Yes  Yes  No  No 
What years does the MYP cover? number   2014-2018  2015-2020  2013-2018       
Nº of districts with microplans that include activities to raise immunization coverage number         250   

System performance

Total Nº districts in country number 335  335  335  335  335  367  367 
Nº districts with DTP3 coverage >=80% number 256  247  192  178  188  189  165 
% of districts with DTP3 coverage >=80% From 0 to 100% 76  74  57  53  56  51  45 
Nº districts with measles (MCV1) coverage >=95% number 172  169  164  91  103  113  76 
% of districts with MCV1 coverage >=95% From 0 to 100% 51  50  49  27  31  31  21 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  Yes  Yes  Yes  No  Yes  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100  100  99  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  Yes  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.